Reshaping the HIV treatment and prevention landscape slide image

Reshaping the HIV treatment and prevention landscape

Separation on track for mid 2022 Objectives gsk Mechanism for separation Unlock potential in New GSK and New Consumer Healthcare GSK 68% ownership: - At least 80% demerged mid 2022 - Strengthen New GSK balance sheet Monetise up to 20% retained to strengthen New GSK balance sheet Maximise shareholder value Intended to be tax efficient compared to alternative separation options 11
View entire presentation